Genomic Study of Tumor Responses in Cancer Patients with Unusually Good or Poor Reactions to Treatment

What this Trial Is About

Researchers are studying how tumors from the same patient can react very differently to the same chemotherapy drugs. This study focuses on understanding the genetic reasons for unusual responsesboth exceptionally good and poorto treatment. The goal is to identify genetic factors that explain why some tumors respond in unexpected ways by examining tumor DNA and molecular characteristics. The study involves analyzing stored tumor samples from patients who showed either an exceptional positive or negative response to cancer treatment. This includes using advanced DNA sequencing techniques, such as Exome sequencing, to investigate the genetic makeup of these tumors. Deceased patients archived tissues may also be included if certain conditions are met. Participants provide tumor samples that researchers will analyze to characterize the tumor genomes over a period of up to two years. The study does not involve new treatments or interventions but focuses on understanding tumor genetics based on past treatment responses. This observational study helps to improve knowledge of cancer behavior and treatment reactions.

Genomic Investigation of Unusual Responders